We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
We created FlyFit with the aim to change the way people travel. Air travel can be stressful, lonely, and unhealthy. On top of this, with average layovers of 2+ hours, flight delays, and hours waiting in security, there is too much unproductive time in airports with limited healthy options to choose from.
days to go: Expired investment: £500,060
Currently supplying restaurants and caterers with meat sourced ethically and now bringing the same service to households. The Ethical Butcher's meat is certified from PFLA farms and the animals have been ethically raised and 100% grass-fed. The team consists of a Michelin Star chef and are winners of The Top 50 Foods in Britain and Ireland in The Great Taste Awards. In its two years of business, The Ethical Butcher has generated £1.37m of revenue and in 2017, their operating profit was £98k. The business receives 200 orders per month, with each invoice averaging £350. Investments will be used to offer a B2C service. Households can have their meat cut and delivered by the next day. The Ethical Butcher will also expand its B2B offerings by supply their meat to gourmet burger bars and increasing the range and variety of meat sold.
days to go: Expired investment: £334,640
A coffee roasting company using ethical means to produce and supply sustainable speciality coffees. Chimney Fire Coffee serves their products to more than 50 retailers, 10 offices and an increasing number of online customers. Their product range varies from espresso blends, to complex filter coffees. Funds are being raised to launch the Office Coffee Club, a service aimed at those working in an office environment. Trials have already taken place at 10 office sites and the company has received praise for their flexibility, quality and price. Whilst at the same time, Chimney Fire Coffee is able to achieve a gross margin of 63%. Over the next 5 years, the company aims to sign up 4,000 customers to the Office Coffee Club.
days to go: Expired investment: £155,550
Fresh Range are changing the food supply with fresher foods delivered direct from local producers. Their technology enables direct sourcing selected to order from local farmers, fishermen, makers and bakers, with consolidated delivery to customers in both private and public sectors. 
days to go: Expired investment: £640,682
The London Crisp Co (LCC) was originally created to be enjoyed in London's pubs. Currently the London Crisp Co. crisps are being stocked in Fullers pubs and are also on the shelves of Tesco. LCC are also in talks with ASDA and Ocado. 
days to go: Expired investment: £352,069
Watmuff & Beckett offer award-winning products including Soups, Risottos & Broths from tangible natural ingredients. The company has produced award-winning range of products that are located in the UK supermarket categories for Fresh Soup. Its products are produced with taste, quality, health and affordability. Watmuff & Beckett aims to take people out of ‘auto-pilot mode’ during lunchtime and feed them a delicious and healthy lunch traceable back to the farmer who produced it. The investment funds will be used to drive launch into national supermarkets, product development, and continued marketing investment.
days to go: Expired investment: £191,750
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph